ArticleOpen forum infectious diseases2023

Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection.

Gregory L Damhorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.